Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Cell Renal Carcinoma”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Early research (Phase 1)Study completedNCT01672775
What this trial is testing

Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

Who this might be right for
Carcinoma, Renal CellRenal Cell Carcinoma of Papillary HistologyRenal Cell Carcinoma With Clear Cell Histology+1 more
Agensys, Inc. 34
Early research (Phase 1)Looking for participantsNCT05752552
What this trial is testing

Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Who this might be right for
Adult Solid TumorAdvanced Solid TumorRefractory Tumor+4 more
DeuterOncology 55
Not applicableActive Not RecruitingNCT06339138
What this trial is testing

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Papillary Renal TumorClear Cell Renal Cell Carcinoma+3 more
Mayo Clinic 589
Testing effectiveness (Phase 2)Active Not RecruitingNCT05411081
What this trial is testing

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

Who this might be right for
Metastatic Papillary Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Study completedNCT01727089
What this trial is testing

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Study completedNCT00688753
What this trial is testing

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Who this might be right for
CarcinomaRenal CellNon Clear Cell Renal Carcinoma+2 more
Novartis Pharmaceuticals 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Large-scale testing (Phase 3)Study completedNCT01120249
What this trial is testing

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 1,545
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Study completedNCT01767636
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Carcinoma of the Collecting Ducts of BelliniChromophobe Renal Cell CarcinomaKidney Medullary Carcinoma+6 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Ended earlyNCT00323791
What this trial is testing

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Medicine and Dentistry of New Jersey 100
Testing effectiveness (Phase 2)Study completedNCT03685448
What this trial is testing

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Testing effectiveness (Phase 2)Study completedNCT00060307
What this trial is testing

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00335556
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Who this might be right for
Childhood Renal Cell CarcinomaClear Cell Renal Cell CarcinomaClear Cell Sarcoma of the Kidney+10 more
Children's Oncology Group 291
Testing effectiveness (Phase 2)Looking for participantsNCT05287945
What this trial is testing

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Oncorena AB 75
Not applicableNot Yet RecruitingNCT07243067
What this trial is testing

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

Who this might be right for
Renal Cell CarcinomaClear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+2 more
Mayo Clinic 300
Early research (Phase 1)Active Not RecruitingNCT05122546
What this trial is testing

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more
City of Hope Medical Center 31
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Looking for participantsNCT05665361
What this trial is testing

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Who this might be right for
Advanced Clear Cell Renal Carcinoma (Ccrcc)Papillary Renal Cell Carcinoma (Prcc)
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Study completedNCT00726323
What this trial is testing

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 74
Load More Results